Patent · US Expired

Imidazonaphthyridines

US6797716B2 · kind B2 · utility

0Cited by
36References
29Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 3, 2003
Grant dateSep 28, 2004
Priority date
Expiry dateMay 16, 2023

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor. The compounds exhibit antiviral and antitumor properties. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.